[Federal Register Volume 69, Number 153 (Tuesday, August 10, 2004)]
[Notices]
[Page 48525]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-18172]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated March 5, 2004, and published in the Federal 
Register on March 15, 2004, (69 FR 12182), Stepan Company, Natural 
Products Department, 100 W. Hunter Avenue, Maywood, New Jersey 07607, 
made application by renewal to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of the basic classes of 
controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cocaine (9041).............................  II
Benzoylecgonine (9180).....................  II
------------------------------------------------------------------------

    The company plans to manufacture bulk controlled substances for 
distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Stepan Company to manufacture the listed basic classes of controlled 
substances is consistent with the public interest at this time. DEA has 
investigated Stepan Company to ensure that the company's registration 
is consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above 
named company is granted registration as a bulk manufacturer of the 
basic classes of controlled substances listed.

    Dated: July 28, 2004.
Joseph T. Rannazzisi,
Deputy Director, Office of Diversion Control Drug Enforcement 
Administration.
[FR Doc. 04-18172 Filed 8-9-04; 8:45 am]
BILLING CODE 4410-09-M